KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) FCF Margin (2018 - 2025)

Historic FCF Margin for Castle Biosciences (CSTL) over the last 8 years, with Q3 2025 value amounting to 9.39%.

  • Castle Biosciences' FCF Margin fell 103800.0% to 9.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.39%, marking a year-over-year decrease of 36900.0%. This contributed to the annual value of 11.0% for FY2024, which is 197600.0% up from last year.
  • Per Castle Biosciences' latest filing, its FCF Margin stood at 9.39% for Q3 2025, which was down 103800.0% from 13.41% recorded in Q2 2025.
  • Castle Biosciences' FCF Margin's 5-year high stood at 107.51% during Q4 2021, with a 5-year trough of 170.81% in Q2 2021.
  • In the last 5 years, Castle Biosciences' FCF Margin had a median value of 15.6% in 2023 and averaged 14.09%.
  • Per our database at Business Quant, Castle Biosciences' FCF Margin crashed by -2631800bps in 2021 and then surged by 1409400bps in 2022.
  • Quarter analysis of 5 years shows Castle Biosciences' FCF Margin stood at 107.51% in 2021, then tumbled by -119bps to 20.31% in 2022, then surged by 210bps to 22.37% in 2023, then fell by -13bps to 19.46% in 2024, then tumbled by -52bps to 9.39% in 2025.
  • Its last three reported values are 9.39% in Q3 2025, 13.41% for Q2 2025, and 12.25% during Q1 2025.